Key result
Early Huntington's disease is linked to sympathetic hyperfunction, shifting to autonomic failure in advanced stages.
Why the study?
The impact of Huntington's disease on autonomic nervous system functioning across disease stages was investigated.
Does Huntington's disease affect autonomic nervous system functioning across different stages of disability?
Observational (n=33)
Does Huntington's disease affect autonomic nervous system functioning across different stages of disability?
p-value: p=<0.05
Huntington's disease is associated with early sympathetic hyperactivity in asymptomatic and mild stages, progressing to autonomic hypofunction in advanced stages.
Autonomic monitoring may be warranted in moderate HD; leaves open whether dysfunction predicts events or warrants intervention.
To investigate whether Huntington's disease (HD) affects autonomic nervous system (ANS) functioning 33 subjects with positive genetic test results were studied. The subjects were classified according to Shoulson and Fahn (S&F) HD disability scale into three subgroups: subgroup 1 (eight asymptomatic gene carriers), subgroup 2 (13 mildly disabled HD patients) and subgroup 3 (eight moderately and four severely disabled HD patients). A battery of cardiovascular autonomic tests (Valsalva maneuver, deep breathing test, sustained handgrip test, orthostatic test) and the spectral analysis of heart rate variability (HRV) were performed. The results were compared with a group of matched controls. In subgroup 1, there was a higher power of low-frequency band (LFB) (P < 0.05). In subgroup 2 a higher power of LFB was detected, LFB/high-frequency band (HFB) coefficient was increased and the blood pressure response to sustained handgrip was elevated (P < 0.05). Subgroup 3 showed significantly lower blood pressure response to sustained handgrip, lower respiratory (P < 0.05) and orthostatic ratio (P < 0.01). Our results suggest that sympathetic hyperfunction is present in asymptomatic gene carriers and mildly disabled HD patients. Contrary to that, ANS hypofunction was found in advanced HD patients.
No takes yet. Share an insight, caveat, or question.
Kobal et al. (2004) conducted an observational in Huntington's disease (n=33). Huntington's disease vs. Matched controls was evaluated on Autonomic nervous system functioning (cardiovascular autonomic tests and HRV spectral analysis) (p=<0.05). Huntington's disease gene carriers and mildly disabled patients exhibited sympathetic hyperfunction (higher low-frequency band power, P<0.05), whereas advanced patients showed autonomic hypofunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: